Publications
2020
2019
- Enquête sur la couverture vaccinale des enfants québécois pour les vaccins administrés avant l’entrée scolaire, 2017
- Maladies évitables par la vaccination à déclaration obligatoire au Québec : rapport de surveillance 2014-2017
- Choix des vaccins à utiliser dans le programme de vaccination contre l’influenza au Québec
- Impact épidémiologique de la campagne de vaccination contre le méningocoque de sérogroupe B dans la région du Saguenay–Lac-Saint-Jean, en 2014 : rapport au 30 juin 2018
2018
2016
- Épidémiologie descriptive des maladies à déclaration obligatoire évitables par la vaccination au Québec, 2011-2013
- Rapport final de surveillance de la sécurité de la vaccination des jeunes de 20 ans et moins contre le méningocoque de sérogroupe B au Saguenay–Lac-Saint-Jean
- Estimation des hospitalisations attribuables à l’influenza selon différentes méthodes
Publications
2005
- Nationwide canadian study of hepatitis a antibody prevalence among children eight to thirteen years old
- Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons
- Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country
2004
- Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons
- Risk and prevention of meningococcal disease among education workers: A review
2003
- [Why are some children incompletely vaccinated at the age of 2?]
- A population-based comparison between travelers who consulted travel clinics and those who did not
2002
- Preadolescent non- and hyporesponders following three doses of hepatitis B vaccine need only one more dose
- Ineffectiveness of the current strategy to prevent hepatitis A in travelers
2001
- Most ten-year-old children with negative or unknown histories of chickenpox are immune
- [Lack of conviction about vaccination in certain Quebec vaccinators]
- Effectiveness of a single dose of acellular pertussis vaccine to prevent pertussis in children primed with pertussis whole cell vaccine
- Importance of attributable risk in monitoring adverse events after immunization: hepatitis B vaccination in children